FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

37435911000001105: Emselex 7.5mg modified-release tablets (CST Pharma Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 07-Aug 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
325321000001111 Emselex 7.5mg modified-release tablets (CST Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
325341000001118 Emselex 7.5mg modified-release tablets (CST Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Emselex 7.5mg modified-release tablets (CST Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel Import - supplier (qualifier value) false Inferred relationship Existential restriction modifier
Emselex 7.5mg modified-release tablets (CST Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Emselex 7.5mg modified-release tablets (CST Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Emselex 7.5mg modified-release tablets (CST Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Emselex 7.5mg modified-release tablets (CST Pharma Ltd) Is a Darifenacin 7.5mg modified-release tablets false Inferred relationship Existential restriction modifier
Emselex 7.5mg modified-release tablets (CST Pharma Ltd) Is a Emselex true Inferred relationship Existential restriction modifier
Emselex 7.5mg modified-release tablets (CST Pharma Ltd) Has specific active ingredient Darifenacin hydrobromide true Inferred relationship Existential restriction modifier
Emselex 7.5mg modified-release tablets (CST Pharma Ltd) Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Emselex 7.5mg modified-release tablets (CST Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Darifenacin true Inferred relationship Existential restriction modifier
Emselex 7.5mg modified-release tablets (CST Pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Emselex 7.5mg modified-release tablets (CST Pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Emselex 7.5mg modified-release tablets (CST Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Emselex 7.5mg modified-release tablets (CST Pharma Ltd) Is a Darifenacin 7.5mg modified-release tablets true Inferred relationship Existential restriction modifier
Emselex 7.5mg modified-release tablets (CST Pharma Ltd) Is a Darifenacin 7.5mg m/r tablet false Inferred relationship Existential restriction modifier
Emselex 7.5mg modified-release tablets (CST Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Emselex 7.5mg modified-release tablets (CST Pharma Ltd) 28 tablet Has AMP True Emselex 7.5mg modified-release tablets (CST Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start